Ad
ACRS Short Information Aclaris Therapeutics Inc.
home / stock / acrs / acrs short
Short Information | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 2,472,961 |
| Total Actual Volume | 14,992,554 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 123,648 |
| Average Short Percentage | 17.01% |
Is there a ACRS Short Squeeze or Breakout about to happen?
See the ACRS Short Analysis for free Sign up or Login
Powered by Squeeze Report
ACRS Twenty Trading Day's Volume to Short Volume Chart
ACRS Twenty Trading Day Price Chart
ACRS Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-13-2025 | $1.5 | $1.47 | $1.55 | $1.47 | 467,122 | 55,348 | 11.85% |
| 06-12-2025 | $1.57 | $1.53 | $1.57 | $1.515 | 420,505 | 52,247 | 12.42% |
| 06-11-2025 | $1.53 | $1.57 | $1.59 | $1.4838 | 846,581 | 162,109 | 19.15% |
| 06-10-2025 | $1.5 | $1.51 | $1.55 | $1.45 | 299,379 | 39,632 | 13.24% |
| 06-09-2025 | $1.55 | $1.49 | $1.55 | $1.465 | 786,932 | 112,728 | 14.32% |
| 06-06-2025 | $1.55 | $1.53 | $1.645 | $1.53 | 737,323 | 149,069 | 20.22% |
| 06-05-2025 | $1.63 | $1.56 | $1.63 | $1.535 | 637,246 | 97,375 | 15.28% |
| 06-04-2025 | $1.48 | $1.61 | $1.6499 | $1.47 | 1,689,307 | 239,036 | 14.15% |
| 06-03-2025 | $1.45 | $1.47 | $1.51 | $1.4195 | 427,751 | 89,966 | 21.03% |
| 06-02-2025 | $1.47 | $1.44 | $1.5301 | $1.42 | 646,039 | 134,717 | 20.85% |
| 05-30-2025 | $1.45 | $1.46 | $1.475 | $1.39 | 751,245 | 97,986 | 13.04% |
| 05-29-2025 | $1.44 | $1.46 | $1.46 | $1.38 | 827,345 | 192,471 | 23.26% |
| 05-28-2025 | $1.36 | $1.41 | $1.56 | $1.35 | 2,811,704 | 385,617 | 13.71% |
| 05-27-2025 | $1.32 | $1.27 | $1.34 | $1.27 | 623,977 | 70,506 | 11.3% |
| 05-23-2025 | $1.25 | $1.26 | $1.285 | $1.22 | 404,728 | 64,091 | 15.84% |
| 05-22-2025 | $1.28 | $1.26 | $1.3111 | $1.25 | 462,233 | 95,134 | 20.58% |
| 05-21-2025 | $1.35 | $1.29 | $1.38 | $1.27 | 641,660 | 141,595 | 22.07% |
| 05-20-2025 | $1.3 | $1.35 | $1.3775 | $1.28 | 489,120 | 93,743 | 19.17% |
| 05-19-2025 | $1.29 | $1.3 | $1.335 | $1.275 | 531,215 | 119,593 | 22.51% |
| 05-16-2025 | $1.2 | $1.31 | $1.32 | $1.18 | 491,142 | 79,998 | 16.29% |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
1.96% G/L:
$1.47 Last:
467,122 Volume:
$1.50 Open:
$1.47 Close:
Aclaris Therapeutics Inc. Website:
Ad
-
- Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time, and Affinity to Thymic Stromal Lymphopoietin (TSLP) - - Top Line Results Expected in the Second Half of 2026 - WAYNE, Pa., June 02, 2025 (GLOBE NEWSWIRE) ...
-
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferen...
-
WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Aclaris’ Chief Executive Officer Neal Walker and other me...